SLC19A1 and hematologic disorder: A single nucleotide polymorphism (SNP) of the SLC19A1 gene was reported to induce a difference in the transport and toxicity of methotrexate, an antifolate drug inhibiting DHFR, in patients with hematological malignancies [31].